Document is current
Any future updates will be listed below
-
Authors
Mariapun, Shivaani
Eriksson, Mikael
Tai, Mei-Chee
Mohd Taib, Nur Aishah
Yip, Cheng Har
Rahmat, Kartini
Vachon, Celine M.
Lindstrom, Sara
Li, Jingmei
Hartman, Mikael
Hall, Per
Easton, Douglas F.
Ho, Weang-Kee
Teo, Soo-Hwang
-
Funding
Funding for this research was provided by:
Malaysian Ministry of Higher Education High Impact Research Grant (UM.C/HIR/MOHE/06, UM.C/HIR/MOHE/06, UM.C/HIR/MOHE/06)
Newton - Ungku Omar Fund (MR/P012930/1, MR/P012930/1, MR/P012930/1)
Wellcome Trust (v203477/Z/16/Z, v203477/Z/16/Z)
- License Information
-
More Information
Article History
Received: 11 August 2024
Accepted: 8 September 2025
First Online: 21 November 2025
Declarations
:
: The Malaysian Mammography Study (MyMammo) and the Malaysian Breast Cancer Genetics (MyBrCa) studies were approved by the Independent Ethics Committee, Ramsay Sime Darby Health Care (reference numbers 201109.4 and 201208.1) and the Medical Ethics Committee, University Malaya Medical Centre (reference numbers 1030.8 and 842.9). Written informed consent was obtained from all study participants. All studies within the Breast Cancer Association Consortium (BCAC), Modifiers of Density Consortium (MODE) and BioBank Japan (BBJ) were approved by their appropriate ethics committee and written informed consent was obtained from all study participants.
: Not applicable.
: The authors declare no nonfinancial conflicts of interest. The authors declare the following financial conflict interests: ME and PH report research grants and a patent on system and method for assessing breast cancer risk using imagery with a license to iCAD, Inc.
